Stanford health economist Kevin Schulman examines how inefficiencies in the health care system affect the nation and individuals — including his own family.
Investigating the generic drug industry and the health care business model
Stanford health economist Kevin Schulman examines how inefficiencies in the health care system affect the nation and individuals — including his own family.
